Results 241 to 250 of about 410,157 (317)

Managing Diabetes One Step at a Time in Low‐ and Middle‐Income Countries: The Promise of Wearable Devices

open access: yesChronic Diseases and Translational Medicine, EarlyView.
ABSTRACT The global burden of diabetes mellitus disproportionately affects low‐ and middle‐income countries (LMICs), where limited healthcare infrastructure hampers timely and effective disease management. Wearable technologies, such as continuous glucose monitors (CGMs), insulin pumps, and fitness trackers, offer a transformative opportunity to bridge
Safayet Jamil   +4 more
wiley   +1 more source

Cytochrome P450 2D6 *17 and *29 Allele Activity for Risperidone Metabolism: Advancing Precision Medicine Health Equity

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
CYP2D6 alleles with low frequency in Eurocentrically biased study populations are often excluded from pharmacogenetic investigation and consequently may have misassigned activity values. This health inequity may be contributing to imprecise dose predictions for CYP2D6‐metabolizing drugs.
Oyinlade Kehinde   +6 more
wiley   +1 more source

Digital Health Literacy in the General Population: National Cross-Sectional Survey Study.

open access: yesJ Med Internet Res
Yoon J   +9 more
europepmc   +1 more source

Neonatal nurses' e-health literacy and technology‑mediated clinical practice: a cross-sectional analysis of digital health competencies and practice patterns. [PDF]

open access: yesBMC Nurs
Ramadan OME   +12 more
europepmc   +1 more source

Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof‐of‐Concept Trial Investigating Decentralization of Trials

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The interest in trials in which activities are being moved to the participants' direct environment, that is, decentralized, has increased in recent years, but limited research has been conducted into the feasibility and acceptability of such approaches.
Mira G.P. Zuidgeest   +15 more
wiley   +1 more source

Recruiting and Consenting Decentralized Clinical Trial Participants—Learnings from the Trials@Home RADIAL Proof‐of‐Concept Trial

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Clinical trials often face recruitment challenges. From the participant's perspective, barriers such as time commitment, travel to sites, and logistical burden, like arranging care duties or time off work, can deter enrolment. Decentralized clinical trials (DCTs) aim to address these by shifting activities closer to participants' homes and using online
Bart Lagerwaard   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy